False positive 2-18Fluroro-deoxy-D-Glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses

Clinical Genitourinary Cancer

Volumn 11, Issue 1, 2013, Pages 66-69

  Wagner, Mathilde ^a   Bellmunt, Joaquim ^b   Boutros, Celine ^a   Bonardel, Gerald ^a   Loriot, Yohann ^a   Albiges, Laurence ^a   Massard, Christophe ^a   Fizazi, Karim ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Chemotherapy; Positron emission tomography; Residual lesions; Seminoma; Unnecessary surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE; PACLITAXEL;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRYPTORCHISM; ECHOGRAPHY; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; MEDIASTINAL SEMINOMA; MEDIASTINUM TUMOR; MULTIPLE CYCLE TREATMENT; PALPATION; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; RETROPERITONEAL TUMOR; SEMINOMA; TESTIS; TESTIS BIOPSY; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; FALSE POSITIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROPERITONEAL NEOPLASMS; SEMINOMA;

EID: 84874548156     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2012.06.006     Document Type: Article

References (14)

1. K. Fizazi, M. Aubelle, R. Delva A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study Proc Am Soc Clin Oncol 27 2009 242s Abstract 5031
2. D. Gholam, K. Fizazi, M.J. Terrier-Lacombe Advanced seminoma-treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients Cancer 98 2003 745 752
3. G.M. Duchesne, S.P. Stenning, N. Aass Radiotherapy after chemotherapy for metastatic seminoma-a diminishing role MRC Testicular Tumour Working Party Eur J Cancer 33 1997 829 835
4. H.S. Puc, R. Heelan, M. Mazumdar Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center J Clin Oncol 14 1996 454 460
5. S. Culine, J.P. Droz Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everything J Clin Oncol 14 1996 2884 2885
6. M. De Santis, C. Bokemeyer, A. Becherer Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma J Clin Oncol 19 2001 3740 3744
7. M. De Santis, A. Becherer, C. Bokemeyer 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial J Clin Oncol 22 2004 1034 1039
8. 1. fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial Ann Oncol 23 2012 59 64
9. K. Fizazi, A. Auperin, S. Le Moulec Stage I seminoma: can 18 fluorodeoxyglucose positron emission tomography (FDG-PET) predict occult dissemination? A phase II study Proc Genitourinary Cancers Symposium 233 2008 Abstract 280
10. J.B. Bomanji, D.C. Costa, P.J. Ell Clinical role of positron emission tomography in oncology Lancet Oncol 2 2001 157 164
11. M. De Santis, J. Pont The role of positron emission tomography in germ cell cancer World J Urol 22 2004 41 46
12. K.N. Ganjoo, R.J. Chan, M. Sharma Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma J Clin Oncol 17 1999 3457 3460
13. S. Hinz, M. Schrader, C. Kempkensteffen The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma J Urol 179 2008 936 940
14. A.W. Stephens, R. Gonin, G.D. Hutchins Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients J Clin Oncol 14 1996 1637 1641